Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
438,889
-
Shares change
-
+96,749
-
Total reported value, excl. options
-
$2,144,000
-
Value change
-
-$22,395
-
Number of buys
-
8
-
Number of sells
-
-5
-
Price
-
$4.88
Significant Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q3 2018
16 filings reported holding RKDA - Arcadia Biosciences, Inc. - Common Stock as of Q3 2018.
Arcadia Biosciences, Inc. - Common Stock (RKDA) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 438,889 shares
of 1,390,020 outstanding shares and own 32% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (277,181 shares), BANK OF MONTREAL /CAN/ (55,000 shares), Virtu Financial LLC (24,702 shares), DIMENSIONAL FUND ADVISORS LP (22,942 shares), WELLS FARGO & COMPANY/MN (21,750 shares), Vanguard Group Inc (18,655 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (13,687 shares), MORGAN STANLEY (2,128 shares), Valeo Financial Advisors, LLC (1,200 shares), and Advisor Group, Inc. (1,000 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.